Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-3 of 3
Keywords: Interleukin 2
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Influence of Immunotherapy (IL2 + LAK + Inhibition of Prostaglandin Synthesis) on Peripheral Blood Immune Parameters and in vitro Cytokine Production in Metastatic Renal Cell Carcinoma
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (1993) 50 (3): 121–128.
Published Online: 03 February 2010
... of inhibition of PG synthesis by piroxicam in combination with interleukin 2 (IL 2) + lymphokine-activated killer (LAK) cell therapy were tested by immunomonitoring. In additon to peripheral blood parameters (lymphocyte subpopulations, neopterin, β 2 -microglobulin, TNF, IL 1, IFNγ) we recorded in vitro...
Journal Articles
Antitumor Effects of Interleukin 2 against Renal Cell Carcinoma: Basic Study and Clinical Application
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (1991) 47 (Suppl. 1): 132–137.
Published Online: 03 February 2010
...K. Marumo; M. Ueno; J. Muraki; M. Tachibana; N. Deguchi; S. Baba; S. Jitsukawa; M. Hata; H. Tazaki In order to determine an optimum mode for systemic administration of recombinant interleukin 2 (rIL2) the effects of rIL2 on lymphocyte-mediated cytotoxicity against renal carcinoma cells were studied...
Journal Articles
Comparison of Immunological Changes between Subcutaneous and Intravenous Route of Administration of IL-2 in Cancer Patients
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (1996) 56 (1): 1–5.
Published Online: 03 February 2010
...A.M.E. Nouri; M. Lowdell; Z. Entazami; B.U. Tezabwala; A. Goode; R.T.D. Oliver The effects of the route of administration of interleukin 2 (IL-2) on the immunological parameters of patients with various malignancies were investigated. The percent mean values for IL-2 receptor (Tac) positive cells...